A new path from lab to patient
Categories:
U researchers turn basic research into a national model that fast-tracks lifesaving therapies toward FDA approval.
Read MoreU researchers turn basic research into a national model that fast-tracks lifesaving therapies toward FDA approval.
Read MoreUnder the new model, DayaMed will retain ownership of any intellectual property developed during the term of the agreement while the U receives upfront equity stake.
Read MoreTrace AQ, a university startup company commercializing the technology, makes the pioneering tool available to the public through Wilkes Center.
Read MoreThe partnership will catalyze growth for early-stage technology companies across various sectors, including software, health and life sciences and financial technology.
Read More